Can vitamin D halt progression of ovarian cancer?

Written By :  Jacinthlyn Sylvia
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2022-07-21 15:00 GMT   |   Update On 2022-07-21 15:01 GMT
Advertisement

Japan: A new study published in Matrix Biology suggests that ovarian cancer (OvCa) spread is mostly mediated by mesothelial cells (MCs), and vitamin D-induced peritoneal repair and normalization of thrombospondin-1 expression may be a novel approach to halting OvCa propagation.

A deadly gynecological disease called ovarian carcinoma spreads to the peritoneum. In the abdominal cavity, mesothelial cells function as barriers that stop cancer cells from sticking to one another. However, people with OvCa, undergo a mesenchymal shift and become cancer-associated mesothelial cells (CAMs), which creates a favorable milieu for tumors to encourage spread. There haven't been many attempts to return CAMs to their former condition, though. Here, Kazuhisa Kitami and colleagues examined whether vitamin D prevented the OvCa from spreading both in vitro and in vivo by inhibiting the mesenchymal transition and restoring MCs.

Advertisement

Utilizing both in vivo and in vitro coculture techniques as well as a xenograft model, the impact of vitamin D on the mutual connection of MCs and OvCa cells was assessed in this study.

The key findings of this study were as follows:

1. Vitamin D replenished the CAMs, and it was shown that the extracellular matrix protein thrombospondin-1, which is clinically linked to a poor prognosis and is significantly expressed in peritoneally metastasized OvCa, encouraged the adhesion and proliferation of OvCa cells.

2. Through Smad-dependent TGF- signaling, TGF-1 produced by OvCa cells increased thrombospondin-1 expression in CAMs.

3. Through vitamin D receptor/Smad3 competition, vitamin D hindered mesenchymal transition in MCs and decreased thrombospondin-1 expression, which helped to significantly reduce peritoneal dissemination in vivo.

4. Importantly, in preclinical models that resemble malignant peritonitis in vivo, vitamin D reversed CAMs from a stable mesenchymal state to the epithelial state and normalized thrombospondin-1 production.

In conclusion, when taken as a whole, the findings point to MCs as important dissemination-determining factors and provide a potential strategy for peritoneal dissemination reduction by preventing the contact between OvCa cells and MCs. Researchers hypothesize that repurposing vitamin D may be a potential method for OvCa dispersion, restoring the peritoneum, and restoring normal THBS-1 expression.

Reference: 

Kitami, K., Yoshihara, M., Tamauchi, S., Sugiyama, M., Koya, Y., Yamakita, Y., Fujimoto, H., Iyoshi, S., Uno, K., Mogi, K., Ikeda, Y., Yokoi, A., Yoshikawa, N., Nishino, K., Niimi, K., Nawa, A., Enomoto, A., & Kajiyama, H. (2022). Peritoneal restoration by repurposing vitamin D inhibits ovarian cancer dissemination via blockade of the TGF-β1/thrombospondin-1 axis. In Matrix Biology (Vol. 109, pp. 70–90). Elsevier BV. https://doi.org/10.1016/j.matbio.2022.03.003

Tags:    
Article Source : Matrix Biology

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News